Shukuan Li

2.2k total citations
28 papers, 1.6k citations indexed

About

Shukuan Li is a scholar working on Biotechnology, Genetics and Biomedical Engineering. According to data from OpenAlex, Shukuan Li has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Biotechnology, 18 papers in Genetics and 13 papers in Biomedical Engineering. Recurrent topics in Shukuan Li's work include Cancer Research and Treatments (26 papers), Virus-based gene therapy research (18 papers) and Nanoplatforms for cancer theranostics (13 papers). Shukuan Li is often cited by papers focused on Cancer Research and Treatments (26 papers), Virus-based gene therapy research (18 papers) and Nanoplatforms for cancer theranostics (13 papers). Shukuan Li collaborates with scholars based in United States, Japan and Belgium. Shukuan Li's co-authors include Robert M. Hoffman, Ming Zhao, Meng Yang, Yuying Tan, Xiaoming Li, Zhijian Yang, Qinghong Han, Mingxu Xu, Sheldon Penman and Ping Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Shukuan Li

27 papers receiving 1.6k citations

Peers

Shukuan Li
Kristine Mann United States
Kyung‐Ju Choi South Korea
Yuebao Zhang United States
Albert Green United States
Michael J. Mendez United States
Shukuan Li
Citations per year, relative to Shukuan Li Shukuan Li (= 1×) peers Qingang Hu

Countries citing papers authored by Shukuan Li

Since Specialization
Citations

This map shows the geographic impact of Shukuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shukuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shukuan Li more than expected).

Fields of papers citing papers by Shukuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shukuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shukuan Li. The network helps show where Shukuan Li may publish in the future.

Co-authorship network of co-authors of Shukuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shukuan Li. A scholar is included among the top collaborators of Shukuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shukuan Li. Shukuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asano, Yohei, Qinghong Han, Shukuan Li, et al.. (2025). Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts. Anticancer Research. 45(6). 2257–2263.
2.
Hoffman, Robert M., Yuying Tan, Shukuan Li, et al.. (2019). Development of Recombinant Methioninase for Cancer Treatment. Methods in molecular biology. 1866. 107–131. 11 indexed citations
3.
Hoffman, Robert M., Zhijian Yang, Yuying Tan, et al.. (2019). Safety and Toxicity of Recombinant Methioninase and Polyethylene Glycol (PEG) Recombinant Methioninase in Primates. Methods in molecular biology. 1866. 211–229. 6 indexed citations
4.
Hoffman, Robert M., Takashi Murakami, Kei Kawaguchi, et al.. (2019). High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Cancer. Methods in molecular biology. 1866. 149–161. 8 indexed citations
5.
Hoffman, Robert M., et al.. (2019). Pilot Phase I Clinical Trial of Methioninase on High-Stage Cancer Patients: Rapid Depletion of Circulating Methionine. Methods in molecular biology. 1866. 231–242. 22 indexed citations
6.
Hoffman, Robert M., Qinghong Han, Kei Kawaguchi, Shukuan Li, & Yuying Tan. (2019). Afterword: Oral Methioninase—Answer to Cancer and Fountain of Youth?. Methods in molecular biology. 311–322. 7 indexed citations
7.
Kawaguchi, Kei, Kentaro Miyake, Qinghong Han, et al.. (2018). Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer. Cancer Letters. 432. 251–259. 71 indexed citations
9.
Kawaguchi, Kei, Qinghong Han, Shukuan Li, et al.. (2018). Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models. Oncotarget. 9(13). 11119–11125. 29 indexed citations
10.
Kawaguchi, Kei, Kentaro Igarashi, Shukuan Li, et al.. (2017). Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget. 8(49). 85516–85525. 63 indexed citations
11.
Zhang, Yong, Makoto Toneri, Nan Zhang, et al.. (2017). Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice. Oncotarget. 8(33). 54616–54628. 22 indexed citations
12.
13.
Yano, Shuya, Shukuan Li, Qinghong Han, et al.. (2014). Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity. Oncotarget. 5(18). 8729–8736. 94 indexed citations
14.
Yano, Shuya, Shukuan Li, Qinghong Han, et al.. (2012). Chemotherapy of methioninase-synchronized S/G2 phase-blocked cancer cells identified by cell cycle-specific fluorescent reporters.. Journal of Clinical Oncology. 30(15_suppl). 1063–1063. 1 indexed citations
15.
Li, Shukuan, Zhijian Yang, Xinghua Sun, et al.. (2005). Sensitive assay of tumor S-adenosyl-methionine and S-adenosyl-homocysteine. Cancer Research. 65. 556–556. 2 indexed citations
16.
Yang, Zhijian, Junhua Wang, Takayuki Yoshioka, et al.. (2004). Pharmacokinetics, Methionine Depletion, and Antigenicity of Recombinant Methioninase in Primates. Clinical Cancer Research. 10(6). 2131–2138. 65 indexed citations
17.
Li, Shukuan, Zhijian Yang, Xinghua Sun, et al.. (2004). Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation. Analytical Biochemistry. 330(2). 264–271. 4 indexed citations
18.
Yang, Zhijian, Junhua Wang, Jinbao Xu, et al.. (2004). PEGylation Confers Greatly Extended Half-Life and Attenuated Immunogenicity to Recombinant Methioninase in Primates. Cancer Research. 64(18). 6673–6678. 99 indexed citations
19.
Sun, Xinghua, Zhijian Yang, Shukuan Li, et al.. (2003). In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.. PubMed. 63(23). 8377–83. 81 indexed citations
20.
Li, Shukuan, et al.. (2003). A simultaneous colorimetric assay of free and protein-coupled polyethylene glycol. Analytical Biochemistry. 313(2). 335–337. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026